Breathing extra carbon dioxide to treat sleep apnea after spinal cord injury
Tests daily hypercapnia treatment for sleep apnea in veterans with chronic spinal cord injury.
Key facts
- Who runs it
- VA Office of Research and Development
- Where
- Detroit, United StatesSee the site
- Trial code
- Registry title
- Effect of Hypercapnia Treatment on Respiratory Recovery After Spinal Cord Injury
- Status
- Recruiting
- People taking part
- 30 people, planned
- Started
- 1 Mar 2023
- Expected to end
- 28 Feb 2027
- Type of study
- Interventional, 3 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Hypercapnia treatment
- Record updated
- 2 April 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with long-term spinal cord injury who have breathing problems during sleep. It is also looking for adults without spinal cord injury who have obstructive sleep apnea.
- Age
- 18 Years to 89 Years
- Sex
- All sexes
- Disease stage
- Spinal cord injury for more than 6 months, ASIA grade A to D, with signs of sleep-disordered breathing. People without spinal cord injury must have obstructive sleep apnea (OSA).
- Earlier treatment
- People on continuous breathing machine support cannot join. PAP therapy for sleep breathing problems is allowed.
Main reasons for not taking part
- Severe heart failure with ejection fraction <35%
- Recent stroke, heart attack, surgery or hospital stay that may affect sleep
- Alcohol or drug abuse with less than 90 days sober
- High carbon dioxide when breathing on your own (end-tidal CO2 >50 mmHg)
- Unable to give consent yourself, or feeling too ill to take part
The registry criteria, word for word
Show all 14 criteriaShow less
Who can take part
- Adult patients with chronic SCI/D (>6 months post-injury)
- American Spinal Injury Association (ASIA) classification A-D who have evidence of SDB (excluding those with no evidence of a neurologic deficit based on ASIA classification)
- Able-bodied patients (without SCI/D0 who have OSA
Who cannot take part
- Receiving continuous mechanical ventilation (except PAP therapy which is considered usual treatment for SDB
- recent surgery
- stroke
- acute myocardial infarction
- Severe congestive heart failure with ejection fraction <35%
- Recent health event that may affect sleep
- hospitalization
- Alcohol or substance abuse (<90 days sobriety)
- Self-described as too ill to engage in study procedures
- Evidence of hypercapnia on spontaneous breathing (end-tidal CO2 >50 mmHg)
- Unable to provide self-consent for participation
The main criteria, as questions
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 89 years old?
Where in United States
- John D. Dingell VA Medical Center, Detroit, MIDetroit, United StatesContact: Abdulghani Sankari, MD PhDTaking people
About the trial
What the trial wants to find out
It is estimated that 1,275,000 people in the United States alone live with spinal cord injury, including around 100,000 Veterans with spinal cord injury, making the V.A. the largest integrated health care system in the world for spinal cord injuries injury care. New therapies are needed to prevent the morbidities and mortalities associated with the high prevalence of respiratory disorders in Veterans with spinal cord injury. The current research project and future studies would set the base for developing innovative therapies for this disorder. This proposal addresses a new therapeutic intervention for sleep apnea in spinal cord injury. The investigators hypothesized that daily hypercapnia treatments improve respiratory symptoms and alleviate sleep apnea in patients with chronic spinal cord injury. The investigators will perform a pilot study to examine the impact of daily hypercapnia treatments for-two week durations among Veterans with spinal cord injury. The investigators believe that this novel approach to treating sleep apnea and will yield significant new knowledge that improves the health and quality of life of these patients.
The 3 groups in the trial
- Intervention hypercapnia armExisting treatment, for comparison
Intermittent hypercapnia treatment five days per week for two weeks.
Treatment: Hypercapnia treatment
- SCDTreatment being tested
Intermittent hypercapnia treatment five days per week for two weeks.
Treatment: Hypercapnia treatment
- Able-BodoedTreatment being tested
Intermittent hypercapnia treatment five days per week for two weeks.
Treatment: Hypercapnia treatment
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Effect of Hypercapnia Treatment on Respiratory Recovery After Spinal Cord Injury
- Plain-language title
- Breathing extra carbon dioxide to treat sleep apnea after spinal cord injuryGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Criteria questions
- Built from NCT05536076, who can take part
- Record updated
- 2 April 2026